Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05805_nanopub.RAGjqxxc4r_Rk4-yeYUEP7FE4kiB9rkl_eeWRf2xhjtnI#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05805 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05805 label "NS-2359 [drugbank:DB05805]" assertion.
- drugbank:DB05805 seeAlso DB05805 assertion.
- drugbank:DB05805 description "NS2359 is a triple monoamine re-uptake inhibitor with a new, unique drug profile expected to yield important benefits compared to existing treatments of depression. Enhancing the function of the three neurotransmitters serotonin, noradrenalin and dopamine, NS2359 has a desired "triple-mode-of-action". This mode of action is expected to produce an optimal reduction in all disease symptoms and the possibility of an earlier onset of action compared to antidepressants already on the market." assertion.
- drugbank:DB05805 identifier "drugbank:DB05805" assertion.
- drugbank:DB05805 title "NS-2359" assertion.
- drugbank:DB05805 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05805 drugbank_vocabulary:drugbank-id "DB05805" assertion.
- drugbank:DB05805 bio2rdf_vocabulary:x-identifiers.org DB05805 assertion.
- drugbank:DB05805 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05805" assertion.
- drugbank:DB05805 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05805 bio2rdf_vocabulary:identifier "DB05805" assertion.